Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt-Reference-Cited by-同舟云学术

Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt

Published:2020-05-28 Issue:22 Volume:9 Page:
ISSN:2576-098X
Container-title:Microbiology Resource Announcements
language:en
Short-container-title:Microbiol Resour Announc

Author:

Kandeil Ahmed¹^ORCID,Mostafa Ahmed¹,El-Shesheny Rabeh¹,Shehata Mahmoud¹,Roshdy Wael H.²,Ahmed Shymaa Showky²,Gomaa Mokhtar¹,Taweel Ahmed El¹,Kayed Ahmed E.¹,Mahmoud Sara H.¹,Moatasim Yassmin¹,Kutkat Omnia¹,Kamel Mina Nabil¹,Mahrous Noura¹,Sayes Mohamed El¹,Guindy Nancy M. El²,Naguib Amal²,Ali Mohamed A.¹

Affiliation:

1. Center of Scientiﬁc Excellence for Inﬂuenza Viruses, National Research Centre, Giza, Egypt

2. Central Public Health Laboratory, Ministry of Health and Population, Cairo, Egypt

Abstract

This report announces the complete genome sequences of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolates detected in Egypt. The isolates were obtained from oropharyngeal swab specimens from two Egyptians in Upper and Lower Egypt. Sequence analysis showed mutations that differentiate Egyptian strains from the reference strain 2019-nCoV WHU01.

Funder

National Research Centre

Publisher

American Society for Microbiology

Subject

Genetics,Immunology and Microbiology (miscellaneous),Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/MRA.00489-20

Reference3 articles.

1. Coronaviruses

2. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

3. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel inhalable nano-based/microparticles for enhanced sustained pulmonary delivery of remdesivir - a patient malleable treatment for coronaviruses infection: in vitro aerosolization, cytotoxicity assays and antiviral activity studies.;Journal of Drug Delivery Science and Technology;2024-09

2. Antiviral potential of rosuvastatin and hesperidin in combination with favipiravir liposomal nanoformulations in targeting the main protease (Mpro) of SARS-CoV-2: Molecular docking, molecular dynamics and in-vitro studies;Journal of Drug Delivery Science and Technology;2024-08

3. Assessment of toxicity and antimicrobial performance of polymeric inorganic coagulant and evaluation for eutrophication reduction;Scientific Reports;2024-02-09

4. Antiviral activity of pyrazole derivatives bearing a hydroxyquinoline scaffold against SARS-CoV-2, HCoV-229E, MERS-CoV, and IBV propagation;RSC Advances;2024

5. Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E;Microorganisms;2023-11-15